Navigation Links
TEI Biosciences Chairman, President and CEO Yiannis Monovoukas Named Ernst & Young Entrepreneur Of The Year® 2011 New England Award Semifinalist
Date:4/20/2011

BOSTON, April 20, 2011 /PRNewswire/ -- TEI Biosciences today announced that Yiannis Monovoukas, Ph.D., M.B.A., its Chairman, President and CEO, is an Ernst & Young Entrepreneur Of The Year® 2011 New England Award semifinalist. The program recognizes entrepreneurs who demonstrate excellence and extraordinary success in such areas as innovation, financial performance, and personal commitment to their businesses and communities.  Dr. Monovoukas was selected as a semifinalist by a panel of independent judges.  Award winners will be announced on 15 June 2011.

"It's a true honor to be in the company of such talented entrepreneurs, in such an innovative and dynamic part of the country.  This recognition reflects the exciting things we have accomplished at TEI, but we're even more enthusiastic about the opportunities that lie ahead," said Dr. Monovoukas.

The Ernst & Young Entrepreneur Of The Year Program celebrates its 25th anniversary this year and recognizes business leaders in more than 50 countries throughout the world.

About TEI Biosciences Inc.

A Boston-based, privately-held, leading biomedical company, TEI Biosciences has applied its expertise in regenerative medicine to develop and commercialize novel biologic devices for a broad spectrum of soft tissue repair and regeneration applications -- from dura, tendon and hernia repair to plastic and reconstructive surgery, and wound healing.

TEI sells its products directly and through partnerships with some of the world's major medical device companies.  TEI's marketed products include:

  • SurgiMend® for plastic & reconstructive surgery and abdominal wall reconstruction
  • SurgiMend® PRS for breast reconstruction
  • PriMatrix™ for skin wound management
  • PriMatrix™ Ag Antimicrobial for skin wound management
  • Dure
    '/>"/>

SOURCE TEI Biosciences Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Magellan Biosciences Announces Agreement with Bruker to Provide Microbiology Tools to Battle Drug Resistance
2. Magellan Biosciences and Miacom Diagnostics Team Up to Enable Faster, Easier Identification of Pathogens as Part of Magellans End-to-End Suite of Microbiology Products Designed to Streamline Lab Workflow and Enable Better Treatment Decisions
3. Neurocrine Biosciences Announces Successful Phase IIa Clinical Trial for VMAT2 Inhibitor
4. Sangamo BioSciences and CHDI Foundation Announce Collaboration to Develop ZFP Therapeutic® for Huntingtons Disease
5. Sangamo BioSciences Announces Presentation at the 10th Annual Needham Healthcare Conference
6. Avantra Biosciences Offers Its Proprietary PATH® Slides for Sale
7. Ardea Biosciences Reports Recent Accomplishments and Announces Fourth Quarter and Full-Year 2010 Financial Results
8. Neurocrine Biosciences to Present at the Cowen & Co. 31st Annual Health Care Conference
9. Ardea Biosciences Announces Exercise in Full of Overallotment Option for Common Stock Offering
10. Swift Biosciences Presents Highly Sensitive, Highly Specific qPCR Mutation Detection Data at 18th International Molecular Medicine Tri-Conference
11. Martek Biosciences Inducted into Small Business Innovation Research (SBIR) Hall of Fame
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 30, 2014 Proove Biosciences , ... excited to announce a new genetic test built upon ... Pain Perception Test will provide physicians with an ... pain tolerance levels are stratified between individuals. With this ... a person has a genetic predisposition that will affect ...
(Date:9/30/2014)... , September 30, 2014 ... intuitive browsing of chemistry in documents ... software solutions and consulting services for life science ... information and generate Markush structures from documents. ... organizations intellectual property, however generating and understanding Markush ...
(Date:9/30/2014)... BioHealth Innovation, Inc. (BHI), a ... and increasing access to early-stage funding in ... Tania Fernandez , Ph.D., has joined the BHI ... a member of the management team for a new ... million in seed and early-stage equity investments to therapeutics, ...
(Date:9/30/2014)... 2014 The custom stainless steel fabrication ... Show 2014. The Boston Area Chapter of ISPE (International ... day-long event for Wed., Oct. 1 at Gillette Stadium ... the largest in ISPE Boston’s long history, with more ... attendees expected. , HOLLOWAY AMERICA President David Simpson ...
Breaking Biology Technology:Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2Seasoned Life Sciences Venture Capitalist Tania Fernandez Joins BHI to Help Manage New BioHealth Gap Fund 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 2HOLLOWAY AMERICA to Exhibit at ISPE Boston Product Show 2014 3
... SUNNYVALE, Calif., Sept. 26 Cepheid (Nasdaq:,CPHD) will ... Growth Stock,Conference on October 3, 2007 at 10:40 ... York. John R. Sluis, Cepheid,s Chief Financial Officer ... Officer, will provide,a corporate overview. The webcast, ...
... strategic platform for reducing risk of cancer ... drug development, ... ; MTAX) held its 2007 annual shareholders meeting,(Annual Meeting) on Tuesday, September ... a majority of CTI,s shares are,held by Italian shareholders. At the 2007 ...
... BioInformatics, SINGAPORE, Sept. 26 /Xinhua-PRNewswire/ -- ... Ltd, a leader in reconfigurable computing,applications headquartered ... The,BioIT Alliance is a cross-industry group working ... pace of drug discovery and realize the,potential ...
Cached Biology Technology:Cepheid to Present at William Blair Small-Cap Growth Stock Conference 2Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results 2Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results 3Cell Therapeutics, Inc. (CTI) Announces 2007 Annual Shareholders Meeting Results 4Progeniq Joins Microsoft in Bio IT Alliance 2Progeniq Joins Microsoft in Bio IT Alliance 3
(Date:9/30/2014)... German . ... risky situations such as exposure to predators. Researchers from ... a long-term study on different populations of great tits ... ambient temperature. High metabolic rates and low temperatures were ... birds were more likely to approach potential predators. , ...
(Date:9/30/2014)... of perilous threats in today,s ocean. From overfishing ... fragile coral ecosystems are disappearing at unprecedented rates ... of corals surrounding the island of Moorea in ... tropical environment: coral guard-crabs. New research from the ... scientist Seabird McKeon and the museum,s predoctoral fellow ...
(Date:9/30/2014)... 30, 2014 Winners of The Economist,s prestigious ... scheduled to take place at the JW Marriott Hong Kong on ... winners will share their experiences and the lessons those hold for ... proven innovation over the past decade, will be presented at a ... the summit. It will be the first time the ceremony has ...
Breaking Biology News(10 mins):Risky metabolism 2Smithsonian scientists discover coral's best defender against an army of sea stars 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 2Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 3Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 4Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 5Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 6Hear from The Economist's 2014 Innovation Award Winners at Innovation Summit on October 10th in Hong Kong 7
... led by the Karolinska Institutet, Sweden and the University of ... and the composition of human gastrointestinal bacteria. In a study ... the team outline new evidence suggesting that the human genome ... billions of microbes in the human gastrointestinal tract collectively known ...
... senior author Morris J. Birnbaum, MD, PhD, the Willard ... for Diabetes, Obesity, and Metabolism, Perelman School of Medicine, ... works in a different way than previously understood. Their ... hormone glucagon,s ability to generate an important signaling molecule, ...
... cells in all higher organisms cells need to bind to ... tissues. Mysteries have remained, however, about exactly how cells manage ... Scripps Research Institute (TSRI) have now solved part of this ... α-catenin, which is essential to this process. The ...
Cached Biology News:International study suggests human genes influence gut microbial composition 2Most-used diabetes drug works in different way than previously thought 2New study defines the long-sought structure of a protein necessary for cell-cell interaction 2
The new Silencer siRNA Starter Kit is perfect for researchers new to RNAi. It provides all of the reagents, protocols, and instructions necessary to get underway with siRNA transfection and ensure su...
... the yolk protein Vtg in plasma from juvenile ... biomarker for endocrine disrupting chemicals (EDCs) with estrogenic ... an accepted screening test for the estrogenic effects ... EIA kit is a double-antibody immunometric (sandwich) EIA ...
... sequence is from rat SCAMP 5. The sequence of this ... Q - P - Q - T - Q - Y ... Y - T - Y - S - N(233). ... the polyclonal antibody that reacts with this product and the rat ...
... Have a novel target for which no antibody ... made custom antibodies for a variety of pharmaceutical, ... happy to put our technology and expertise in ... Access to our patented RabMAb development technology , ...
Biology Products: